PREPARATION OF MONOSPECIFIC BRUCELLA ANTI-ABORTUS SERUM BASED ON THERMOEXTRACT FROM S-FORM BRUCELLA
https://doi.org/10.21055/0370-1069-2017-2-78-80
Abstract
Objective of the study is to prepare rabbit monospecific anti-abortus serum to a Brucella S-form thermoextract, as well as to evaluate its activity and specificity. Materials and methods. Utilized was polyvalent hyperimmune serum obtained to Brucella thermoextract. It was adsorbed by a strain of heterologous species Brucella melitensis 16 N. Reference, vaccinal and field Brucella strains were used to estimate the activity and specificity of the serum produced. Results and conclusions. This serum possesses high activity (1:160, 1:320 titer) and specificity, and the results completely coincide with the data specified in the table of differential properties presented in МR 3.1.7.1189-03 “Prophylaxis and laboratory diagnostics of human brucellosis». The outlined method for manufacturing monospecific Brucella anti-abortus serum permits for a considerable decrease in biological hazard for personnel involved in the technological operations.
About the Authors
L. M. МikhailovRussian Federation
78, Trilissera St., Irkutsk, 664047
N. L. Barannikova
Russian Federation
78, Trilissera St., Irkutsk, 664047
L. E. Tokareva
Russian Federation
78, Trilissera St., Irkutsk, 664047
N. M. Andreevskaya
Russian Federation
78, Trilissera St., Irkutsk, 664047
V. A. Мikhailova
Russian Federation
78, Trilissera St., Irkutsk, 664047
V. I. Kuznetsov
Russian Federation
78, Trilissera St., Irkutsk, 664047
K. Yu. Yastremskaya
Russian Federation
78, Trilissera St., Irkutsk, 664047
S. V. Balakhonov
Russian Federation
78, Trilissera St., Irkutsk, 664047
References
1. Vilinskaya S.V., Lyamkin G.I., Lyapustina L.V., Rusanova D.V. [Method for the production of brucellosis monospecific anti-abortus serum]. RF Patent 2375074, 10.12.2009.
2. Dal’vadyants V.G., Lyamkin G.I., Lyapustina L.V., Taran I.F., Lukanina L.M. [Method for the production of monospecific sera for differentiation of brucellosis agent]. RF Patent 2104031, 10.02.1998.
3. Mikhailov L.M., Kalinovsky A.I., Barannikova N.L., Balakhonov S.V., Markov E.Yu., Nikolaev V.B., Kozulina K.Yu., Shestopalov M.Yu., Andreevskaya N.M., Mikhailova V.A., Tatarnikova O.G., Kuznetsov V.I. [Method for the production of antigen preparation from L-form brucella]. RF Patent 2416429, 20.04.2011.
4. Onishchenko G.G., Kutyrev V.V., editors. [Laboratory Diagnostics of Dangerous Infectious Diseases. Practice Guidelines]. 2nd Edition, revised and enlarged. M.: CJSC “Shiko”; 2013. 560 p.
Review
For citations:
Мikhailov L.M., Barannikova N.L., Tokareva L.E., Andreevskaya N.M., Мikhailova V.A., Kuznetsov V.I., Yastremskaya K.Yu., Balakhonov S.V. PREPARATION OF MONOSPECIFIC BRUCELLA ANTI-ABORTUS SERUM BASED ON THERMOEXTRACT FROM S-FORM BRUCELLA. Problems of Particularly Dangerous Infections. 2017;(2):78-80. (In Russ.) https://doi.org/10.21055/0370-1069-2017-2-78-80